Latest News

FDA Approval for Endoform® Silver Dermal Template24 Nov 2017

Aroa Biosurgery has been granted U.S. Food and Drug Administration (FDA) 510(k) clearance for the company’s Endoform® Silver Dermal Template, which allows the company to market and sell this device in the USA.

Continue Reading

Big investment in Aroa Biosurgery‘s Commercial Partner30 Oct 2017

New Zealand biomedical company Aroa Biosurgery faces accelerating growth after a significant investment of up to US$25 million in its surgical partner for commercial expansion.

Continue Reading

CE Mark for Endoform® Dermal Template11 Apr 2017

Aroa Biosurgery has received CE mark for its Endoform® Dermal Template (“EDT”), which allows the company to market and sell this device in the European markets.

Continue Reading
123Next ›